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Abstract 
Over the last few decades, advances have been made in the understanding of myofascial  pain syndrome  epide-
miology, clinical characteristics and aetiopathogenesis, but many  unknowns remain. An integrated hypothesis 
has provided a greater understanding of the  physiopathology of trigger points, which may allow the development 
of new diagnostic,  and above all, therapeutic methods, as well as the establishment of prevention policies  and 
protocols by the health profession. Nevertheless, randomized studies are needed to  provide a better understanding 
and detection of the different factors involved in the  origin of trigger points. 
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Introduction
Myofascial pain associated with trigger points has been 
studied by the medical and dental profession for more 
than a century (1,2). However, various aspects of its 
physiopathology, clinical manifestation and treatment 
remain unclear.
A great diversity of criteria exists for defining myofas-
cial pain. Some authors consider this syndrome to be a 
specific entity, whilst others use a more generic defini-
tion which incorporates a wide range of musculoskel-
etal disorders (2).
Okeson, in 1985, (2) classified muscular pain of mas-
ticatory origin into five categories, one of these being 
myofascial pain associated with trigger points. In the 
present review, Simons and Travell’s (3) definition of 
myofascial pain is used. The aim is to describe myofas-
cial pain syndrome of craniocervical origin, based on 
the principal characteristics described in the literature 
with respect to its epidemiology, clinical characteristics 
and etiopathogeny.
Epidemiology and clinical characteristics
Myofascial pain syndrome associated to trigger points 
(TrPs), is a noninflammatory disorder of musculoskel-
etal origin, associated with local pain and muscle stiff-
ness, characterized by the presence of hyperirritable 
palpable nodules in the skeletal muscle fibers, which are 
termed TrPs (trigger points) (1,3,4). TrPs produce pain 
to any activating stimulus (direct or indirect trauma) 
and can provoke referred pain, referred tenderness, mo-
tor dysfunction, autonomic phenomena and hyperexcit-
ability of the central nervous system (Table 1) (2,5-7).
Myofascial pain is perceived as a dull, non-pulsating 
pain, which can vary from mild discomfort to incapaci-
tating pain, both at rest and during activity; it is rarely 
symmetric and adopts a segmented distribution (non-
dermatomal spinal segmentation pattern)(5).
In most cases referred pain is the main nociceptive 
source perceived by the patient (2). Trigger points are 
detectable only if superficially located in the muscle, or 
if associated with areas of localized spasm (3), their av-
erage size varying between 2 and 10mm (5, 7).
Myofascial pain syndrome is very common in the gen-
eral population and its incidence can be as high as 54% 
in women and 45% in men, although the prevalence of 
patients with TrPs in the masticatory muscles does not 
exceed 25% (8). The most common age at presentation 
is between 27.5 and 50 years, with preference in seden-
tary individuals (5-7). The majority of publications do 
not report significant differences between the two sexes 
(2,3), although a greater prevalence in females has been 
described (1).
Myofascial TrPs are classified as either active or latent 
(5). In its active form the pain is continual, with reduced 
muscular elasticity, muscle weakness and referred pain 
in response to direct pressure (3, 9). The intensity and 
extension of the pain depend mainly on the degree of 
irritability of the TrP. Latent trigger points exhibit the 
same clinical characteristics as active TrPs, although 
they tend to be less severe. Moreover, in the latent 
forms, the pain is induced rather than constant, both in 
the zone of origin of the pain and in that of the referred 
pain (2,3,10). Some authors have even considered that 
the presence of latent TrPs may be connected with the 
genesis of muscle cramps (10).
TrPs may also be classified as primary or secondary 
(2,3), the primary TrPs being those that develop from 
either acute or chronic overloading of the muscle con-
cerned, and where its activation is not due to the action 
of another muscle. Secondary, or satellite, TrPs are the 
result of mechanical stress and/or neurogenic inflam-
mation due to the activity of a primary TrP (3).
Patients with myofascial pain syndrome usually exhibit 
protective habits or reflexes to avoid activating the pain 
(2,3).
TrPs can also produce changes in the function of the 
autonomic nervous system (ANS), which may cause lo-
calized hypothermia, referred cutaneous hypothermia 
and persistent lacrimation. Some authors also make 
reference to proprioceptive changes, such as balance 
problems or tinnitus in patients with myofascial TrPs 
(3,10,11). In some cases local and referred pain from ac-
tive TrPs may be considered a factor related to the pain 
profile of tension-type headaches (12,13). Entrapment 
of the nerve branches that cross the TrP may produce 
sensory and/or motor disturbances due to damage in the 
affected nerve (3).
Other non-painful accompanying symptoms described 
Table 1. Symptomatology of trigger points and their clinical sig-
nificance (2,5-7).
SYMPTOM       CLINICAL SIGNIFICANCE
Taut bands Minor
Local pain which heightens with 
use Major
Local pain on palpation Major
Referred pain Major
Reproducible pain pattern Major
Local twitch response Minor
Reduced extension Minor
50% pain reduction after treatment Major
Non-clinically proven acute maloc-
clusion Minor
Muscle tenderness Minor
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in relation to, or as a consequence of, myofascial pain are 
psychological disorders (Axis II), such as depression and 
anxiety (3,14). Some recent studies indicate that patients 
with TrPs have a higher and more frequent consumption 
of psychotropics than the general population (15). Nu-
merous authors maintain that depressive disorders may 
be brought on by high levels of chronic pain, such that, 
the more intense and prolonged the pain, the deeper the 
depression (6,16). Other studies have found that those 
patients with depression experience pain more acutely, 
which increases the symptoms produced by the disease 
(17), although other authors have questioned whether 
chronic pain could be the consequence of a psychiatric 
problem (18).
Anxiety disorders are also common in patients with 
chronic pain and are manifested in a high number of 
cases as muscular tension which leads to overload and 
fatigue in the masticatory muscles, causing the develop-
ment of TrPs (19). The symptoms of chronic myofascial 
pain can also increase patient anxiety, thereby estab-
lishing a vicious circle (2,3).
Anamnesis, clinical examination and comple-
mentary tests
The diagnosis of myofascial pain is based mainly on an-
amnesis and clinical examination (1-3). Using anamne-
sis information is gathered regarding the type, intensity, 
duration, frequency and location of the pain, as well as 
alleviating or accentuating factors (Table 2) (1,8.15). 
The essential part of the clinical examination is to lo-
cate the TrPs by manual palpation of the cervical and 
facial musculature (3).
Localization of TrPs is based on three basic maneuvers: 
a) direct finger pressure, b) flat palpation, c) pincer pal-
pation. Using the first two techniques, an assessment 
is made of the surface musculature, whilst the third is 
used to evaluate the deeper layers (3). It is necessary 
to wait between 2 and 5 seconds (3,20) after applying 
an appropriate pressure of about 2 kg/cm² (6), in order 
to reproduce the referred pain. The precision and force 
applied during an examination will influence the induc-
tion of this referred pain and, therefore, the diagnosis.
The literature reports poor concurrence between ex-
aminers in the location of TrPs using manual palpa-
tion (3,5,7,20). Cummings et al. (5) after an analysis of 
studies available in the literature, concluded that there 
was a 41 - 50% concordance between examiners when 
diagnosing the presence of a TrP. However, when rul-
ing out their presence, reliability was 85 - 90%. Results 
published by Hsieh et al. (21) show that the stimulation 
of local or referred pain by manual palpation is the most 
reliable diagnostic method for detecting myofascial 
TrPs, whilst the identification of palpable nodules or the 
provocation of a local twitch response present poor reli-
ability between examiners in the majority of available 
studies.
Complementary testing is the third link in a clinical his-
tory, although there is much controversy as to their util-
ity in the diagnosis of myofascial pain syndrome since 
they lack the necessary precision, sensitivity and spe-
cificity (22).
The majority of authors agree that complementary tests 
would be of use in the diagnosis of myofascial pain, as 
long as they were preceded by a proper anamnesis and 
clinical examination (3,6,23). Ultrasound, electromy-
ography, algometry and thermography are some of the 
complementary tests quoted in the literature for diag-
nosis of TrPs. Even so, a detailed analysis of available 
published material reveals that none of these diagnostic 
tests has a scientifically-proven usefulness in the diag-
nosis of myofascial pain disorder, thus better quality 
scientific studies would be required to determine the 
real benefit of their application in detecting TrPs (3,5). 
Within these complementary tests, Ge et al. (24) would 
include dry needling and topographical mapping as 
techniques capable of detecting active TrPs.
Table 2. Factors which increase or decrease painful symptoms of trigger points (1,8,15).
AGGRAVATING FACTORS MODERATING FACTORS
Overuse of musculature Rest
Active stretching Passive stretching
Pressure on trigger point Specific myofascial therapy
Prolonged muscle contraction Non-isometric contraction activity
Cold, damp, viral infections, tension Local warming of trigger point
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Etiopathogeny
Despite the diverse theories, the exact nature of TrPs 
is unknown (2,6), although the combination of the two 
lines of investigation most accepted by the scientific 
community, electrophysiological and histologic, allows 
the proposal of an integrated hypothesis regarding the 
origin of TrPs (25).
This hypothesis postulates that the increased energy 
consumption observed in an active TrP site is caused 
by an abnormal rise in the production and release of 
acetylcholine in the motor endplate in the resting state. 
This rise in activity of the motor endplate produces a 
sustained depolarization of the muscle fibre, caus-
ing incorrect release and reuptake of calcium ions by 
the local sarcoplasmic reticulum. The increase in free 
calcium ions causes a sustained muscle contraction, 
which raises energy demand. The supply of nutrients 
and oxygen is also compromised by the compression of 
nearby blood vessels. This ‘energy crisis’ impedes the 
calcium pump which is responsible for returning the 
free calcium to the sarcomere (segmental reduction) and 
could also initiate the release of algogenic substances, 
producing sensitization of the autonomic and sensory 
nerve endings. This release of neuroactive substances 
helps to further increase the production of acetylcholine 
and/or creating a vicious cycle of events. Both the sus-
tained muscle contraction, produced by the continual 
release of acetylcholine, and the sensitization of local 
nociceptors by the generation of algogenic substances 
would explain clinical findings such as the presence of 
palpable nodules and/or pain arising from palpation of 
TrPs (3,26). Chang et al. (27) demonstrate that over time 
there is neuroaxonal degeneration and neuromuscular 
transmission disorders in muscles with TrPs, and that 
this mechanism is possibly implicated in the degenera-
tion of motor neurones. A recent study by Shah et al. 
(25) provides a solid histochemical basis for this theory, 
as it shows that active TrPs exhibit a biochemical envi-
ronment of inflammatory mediators, neuropeptides, cy-
tokines and catecholamines different from latent TrPs 
or normal muscle areas.
None of the theories regarding the origin of TrPs provide 
a convincing explanation of the phenomenon of referred 
pain of myofascial origin. However, four theories ex-
ist regarding the transmission mechanisms of referred 
pain: the theory of pain transmission via specific nerve 
pathways, the theory of transmission via collateral 
branches in the nerves responsible for the innervation 
of the TrPs, the convergence-projection theory and the 
convergence-facilitation theory, the last two of which 
are linked with the CNS (3). Niddam et al. (28) point out 
that the central response to stimulus of TrPs indicates a 
relationship between somatosensory activity, the limbic 
system and the suppressing right dorsal hippocampal 
activity such that the hyperalgesia, typical of this pain 
syndrome, would be associated with abnormal activity 
in areas which process stimulus intensity and the nega-
tive affect.
The majority of current muscular pain syndrome mod-
els assume the existence of some form of event as 
the cause of muscular pain symptoms (2) either local 
(e.g. dental fractures, muscle fatigue caused by oral 
parafunctional habits and micro or macro muscular 
trauma, orthopaedic disorders, such as disc or class II 
skeletal displacements associated with craneomandibu-
lar problems, certain antihypertensive medicines such 
as calcium channel blockers) or systemic factors (e.g. 
increased emotional tension, endocrine problems, sleep 
disorders, nutritional deficiencies and viral infections) 
(2,3), although in cases of severe painful conditions, the 
importance of these causes in the genesis of the pain is 
not clear(8).
Local or systemic factors increase the predisposition 
of an individual to develop myofascial pain syndrome 
and, if not detected or treated appropriately, become 
perpetuating factors. In some cases, the elimination of 
the perpetuating factors can produce the inactivation 
of the TrPs associated with myofascial pain. In patients 
with chronic myofascial pain, the proper identification 
and treatment of the perpetuating factors can mean the 
difference between success and failure of the treatment 
(3).
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